期刊文献+

血清sTNFR1,sIL-2Ra和IGF-1在食管癌抑郁患者护理干预中的价值 被引量:4

Values of Serum sTNFR-1,sIL-2 Ra and IGF-1 on Depression in Patients with Esophageal Cancer by Nursing Intervention
下载PDF
导出
摘要 目的:分析血清 sTNFR-1,sIL-2Ra和 IGF-1在食管癌抑郁患者护理干预中的价值,探讨了相关血清指标取代Zung抑郁状态问卷(DSI)和汉密尔顿抑郁量表(HAMD)的可能。方法:20例经病理证实的食管癌患者纳入研究。以DSI和 HAMD评估患者抑郁情况。采用酶联免疫吸附试验(ELISA)检测血清 sTNFR1,sIL-2Ra 和 IGF-1。结果诊断为抑郁的69例患者作为研究组,其中32例患者被诊断为抑郁症;51例未出现抑郁的患者作为正常对照组。研究组血清sTNFR-1水平为2.28±0.76 ng/ml,sIL-2Ra为234.54±59.43 ng/ml,IGF-1为297.68±53.47 ng/ml,均明显高于对照组(t=5.356~9.274,P 值均<0.05);在最小抑郁到严重抑郁中血清 sTNFR-1水平分别为1.92±0.42 ng/ml,2.11±0.35 ng/ml,2.33±0.46 ng/ml;sIL-2Ra为215.52±46.21 ng/ml,243.64±61.55 ng/ml,276.78±47.22 ng/ml;IGF-1为272.71±77.48 ng/ml,311.58±91.61 ng/ml,337.75±81.54 ng/ml,这些血清学指标随患者抑郁程度而增加(F=5.084~5.283,P值均<0.05)。结论血清 sTNFR-1,sIL-2Ra和 IGF-1水平可作为护理干预的评价指标,但需进一步临床验证。 Objective To analyze the clinical value of sTNFR-1,sIL-2Ra and IGF-1 on depression in patients with esophageal cancer by comprehensive nursing intervention and explore the possibility of serum indicators to replace DSI and HAMD. Methods 120 patients with pathologically confirmed esophageal cancer were included in the study.Zung depression status inventory (DSI)and hamilton depression rating scale (HAMD)were used to assess depression.Serum sTNFR-1,sIL-2Ra and IGF-1were detected by enzyme-linked immunosorbent assay (ELISA).Results 69 patients were classified as anxiety and depression group,51 patients were as normal control group.There were 32 patients with depression.Serum sTNFR-1, sIL-2Ra and IGF-1 levels in study group was higher than that in the control group (P〈0.05)and these serological indexs increased from the minimal depression,mild-to-moderate depression group to severe depression group (P〈0.05).Conclusion Serum sTNFR-1,sIL-2Ra and IGF-1 levels may be used as evaluation index of nursing intervention,but need further clini-cal validation.
出处 《现代检验医学杂志》 CAS 2014年第6期153-155,共3页 Journal of Modern Laboratory Medicine
关键词 护理干预 食管癌 sTNFR-1 IGF-1 sIL-2Ra comprehensive nursing intervention esophageal cancer sTNFR-1 sIL-2Ra IGF-1
  • 相关文献

参考文献21

  • 1Jemal A,Bray F,Center MM,et al. Global cancer sta-tistics[J]. CA: Cancer J Clin,2011,61(2) :69-90.
  • 2Bray F, Jemal A, Grey N, et al. Global cancer transi-tions according to the Human Development Index(2008 -2030) : a population-based study [J]. LancetOncol,2012,13(8) :790-80l.
  • 3Bodurka-Bevers D,Basen-Engquist K,Carmack CL,etal. Depression, anxiety, and quality of life in patientswith epithelial ovarian cancer [J]. Gynecol Oncol,2000,78(3Ptl):302-308.
  • 4Lloyd-Williams M, Friedman T. Depression in pallia-tive care patients-a prospective study[J]. Eur J Canc-er Care(Engl),2001,10(4) : 270-274.
  • 5Jia L,Jiang SM,Shang YY,et al. Investigation of theincidence of pancreatic cancer-related depression andits relationship with the quality of life of patients[J].Digestion,2010,82(1) :4-9.
  • 6Lim CC, Devi MK,Ang E. Anxiety in women withbreast cancer undergoing treatment: a systematic re-view[J]. Int J Evid Based Healthc,2011, 9 ( 3 ) : 215-235.
  • 7Reece JC, Chan YF,Herbert J, et al. Course of de-pression, mental health service utilization and treat-ment preferences in women receiving chemotherapyfor breast cancer [J]. General Hospital Psychiatry,2013,35⑷:376-381.
  • 8Hammerlid E,Silander E, Hornestam L,et al. Health-related quality of life three years after diagnosis ofhead and neck cancer-a longitudinal study [J]. HeadNeck 2001,23(2):113-125.
  • 9de Leeuw JR,de Graeff A,Ros WJ , et al. Prediction ofdepressive symptomatology after treatment of headand neck cancer:the influence of pre-treatment physi-cal and depressive symptoms, coping, and social sup-port[J]. Head Neck,2000,22(8) :799-807.
  • 10de Leeuw JR, de Graeff A, Ros WJ, et al. Predictionof depression 6 months to 3 years after treatment ofhead and neck cancer[J]. Head Neck,2001,23(10):892-898.

二级参考文献46

  • 1郑杰,姜藻.肿瘤性抑郁症[J].中国肿瘤临床与康复,2006,13(1):81-85. 被引量:14
  • 2李文波,许明智,贾福军.抑郁症与生长激素轴功能的研究进展[J].国际精神病学杂志,2007,34(2):71-74. 被引量:3
  • 3中国行为医学科学编辑委员会编.行为医学量表手册[M].北京:中华医学电子音像出版社,2005.210-211,217-218.
  • 4Dalton So, Boesen EH, RossL, et al. Mind and cancer: do psychological factors cause cancer? [J]. European Journal of Cancer,2002,38 : 1313.
  • 5Mark A Moyad, Kenneth J Pienta. Mind-body effect: insulin-like growth factor-Ⅰ, clinical depression and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance? [J]. UROLOGY, 59 ( Supplement 4A ) ,2002.
  • 6Bailey PK, Geyen DJ, Scott - Gumell K, et al. Understanding and treating depression among cancer patients[J]. Int J Gynecol Cancer,2005,15:203.
  • 7Robyn L Osborn, Angelique C Demoncada, Michael Feuerstein. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors : meta - analyses [J]. Int J Psychiatry in Medicine,2006,36( 1 ) : 13.
  • 8M Spiliotaki, V Salpeas, P Malitas,et al. Altered glucocorticold receptor signaling cascade in lymphocytes of bipolar disorder patients [J]. Psychoneuro - endocrinology 2006, 31 : 748.
  • 9Yirmiya, R. Depression in medical illness[ J]. West J Med,2000,173 : 333.
  • 10Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-1 related to neuroprotection,regeneration, and functional plasticity in the adult brain [ J]. Scientiff c World Journal, 2006,6 : 53.

共引文献13

同被引文献24

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部